Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
University of Washington
Hackensack Meridian Health
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
University of Washington
Alliance for Clinical Trials in Oncology
Universität des Saarlandes
PrECOG, LLC.
Insel Gruppe AG, University Hospital Bern
University of Miami
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
Weill Medical College of Cornell University
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Mayo Clinic
SCRI Development Innovations, LLC
Thomas Jefferson University
Washington University School of Medicine
City of Hope Medical Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
University of Wisconsin, Madison
Stanford University
Academic and Community Cancer Research United
Memorial Sloan Kettering Cancer Center
University of Miami
Weill Medical College of Cornell University
City of Hope Medical Center
City of Hope Medical Center
Northwestern University
Roswell Park Cancer Institute
Stanford University
PrECOG, LLC.
University of Nebraska
University of Nebraska
Vanderbilt-Ingram Cancer Center
University of Nebraska
University of Alabama at Birmingham
University of Nebraska
OHSU Knight Cancer Institute
City of Hope Medical Center
Rutgers, The State University of New Jersey
University of Pennsylvania